NBRV Sinks Deeper Into Penny Stock Territory

The security is nearing its annual lows

Digital Content Manager
Dec 20, 2019 at 10:21 AM
facebook twitter linkedin

The shares of Nabriva Therapeutics (NASDAQ:NBRV) are sinking even deeper into penny stock territory today -- down 18.6% to trade at $1.40 -- after the company said it has entered into an agreement with undisclosed institutional investors for the purchase and sale of a $20 million registered direct offering. This comes despite the drugmaker resubmitting its marketing application to the Food and Drug Administration (FDA) for Contepo, its treatment for urinary tract infections. The announcements have NBRV on pace for its biggest one-day drop since May. 

NBRV has been chopping lower for the better part of the year, with overhead pressure emerging at the 100-day moving average. While the $1.70 region served as support for the pharma stock for the better part of the year, the shares have breached this level today. For the quarter, Nabriva is now down 32%. 

Those covering NBRV are still extremely bullish, which could leave the door open for more downgrades. Right now, six of the seven in coverage call it a "buy" or better. Plus, the consensus 12-month price target is more than five times last night's close. 

On the other hand, short interest has begun to inch higher -- up almost 4% in the last two reporting periods. The 4.2 million shares sold short now represent a solid 5.4% of the stock's available float, and 5.6 times the average daily trading amount. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners